It was shown that in the brains of donors with cognitive dysfunction the GLT1 expression was decreased, while in brains of donors without cognitive dysfunction GLT1 expression was similar to donors without AD pathology (Jacob et al., 2007; Scott et al., 2011; Kobayashi et al., 2018). The gene discussed is SLC1A2; the disease is Alzheimer disease.